|
1
|
Lomas A, Leonardi-Bee J and Bath-Hextall
F: A systematic review of worldwide incidence of nonmelanoma skin
cancer. Br J Dermatol. 166:1069–1080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Abaseri TB, Fuhrman J, Trempus C,
Shendrik I, Tennant RW and Hansen LA: Chemoprevention of UV
light-induced skin tumorigenesis by inhibition of the epidermal
growth factor receptor. Cancer Res. 65:3958–3965. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kyriakis JM and Avruch J: Protein kinase
cascades activated by stress and inflammatory cytokines. Bioessays.
18:567–577. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rosette C and Karin M: Ultraviolet light
and osmotic stress: Activation of the JNK cascade through multiple
growth factor and cytokine receptors. Science. 274:1194–1197. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lewis CM, Glisson BS, Feng L, Wan F, Tang
X, Wistuba II, El-Naggar AK, Rosenthal DI, Chambers MS, Lustig RA
and Weber RS: A phase II study of gefitinib for aggressive
cutaneous squamous cell carcinoma of the head and neck. Clin Cancer
Res. 18:1435–1446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alam M and Ratner D: Cutaneous
squamous-cell carcinoma. N Engl J Med. 344:975–983. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chang CY, Kuan YH, Ou YC, Li JR, Wu CC,
Pan PH, Chen WY, Huang HY and Chen CJ: Autophagy contributes to
gefitinib-induced glioma cell growth inhibition. Exp Cell Res.
327:102–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Merlino GT, Xu YH, Ishii S, Clark AJ,
Semba K, Toyoshima K, Yamamoto T and Pastan I: Amplification and
enhanced expression of the epidermal growth factor receptor gene in
A431 human carcinoma cells. Science. 224:417–419. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Degenhardt K, Mathew R, Beaudoin B, Bray
K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang ZJ, Chee CE, Huang S and Sinicrope
FA: The role of autophagy in cancer: therapeutic implications. Mol
Cancer Ther. 10:1533–1541. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Klionsky DJ, Abdalla FC, Abeliovich H,
Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M,
Agostinis P, Aguirre-Ghiso JA, et al: Guidelines for the use and
interpretation of assays for monitoring autophagy. Autophagy.
8:445–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou L, Wang Y, Zhou M, Zhang Y, Wang P,
Li X, Yang J, Wang H and Ding Z: HOXA9 inhibits HIF-1α-mediated
glycolysis through interacting with CRIP2 to repress cutaneous
squamous cell carcinoma development. Nat Commun. 9:14802018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feoktistova M, Geserick P and Leverkus M:
Crystal violet assay for determining viability of cultured cells.
Cold Spring Harbor Protocols. 2016:pdb.prot087379. 2016. View Article : Google Scholar
|
|
15
|
Thomé MP, Filippi-Chiela EC, Villodre ES,
Migliavaca CB, Onzi GR, Felipe KB and Lenz G: Ratiometric analysis
of acridine orange staining in the study of acidic organelles and
autophagy. J Cell Sci. 129:4622–4632. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lynch TJ, Bell DW, Sordella R,
Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat
SM, Supko JG, Haluska FG, et al: Activating mutations in the
epidermal growth factor receptor underlying responsiveness of
non-small-cell lung cancer to gefitinib. N Engl J Med.
350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ciardiello F and Tortora G: EGFR
antagonists in cancer treatment. N Engl J Med. 358:1160–1174. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Johnston JB, Navaratnam S, Pitz MW,
Maniate JM, Wiechec E, Baust H, Gingerich J, Skliris GP, Murphy LC
and Los M: Targeting the EGFR pathway for cancer therapy. Curr Med
Chem. 13:3483–3492. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bethune G, Bethune D, Ridgway N and Xu Z:
Epidermal growth factor receptor (EGFR) in lung cancer: An overview
and update. J Thorac Dis. 2:48–51. 2010.PubMed/NCBI
|
|
20
|
Henson ES and Gibson SB: Surviving cell
death through epidermal growth factor (EGF) signal transduction
pathways: Implications for cancer therapy. Cell Signal.
18:2089–2097. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kobayashi S, Boggon TJ, Dayaram T, Jänne
PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG and Halmos
B: EGFR mutation and resistance of non-small-cell lung cancer to
gefitinib. N Engl J Med. 352:786–792. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Galluzzi L, Aaronson SA, Abrams J, Alnemri
ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren
K, Borner C, et al: Guidelines for the use and interpretation of
assays for monitoring cell death in higher eukaryotes. Cell Death
Differ. 16:1093–1107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Galluzzi L, Pietrocola F, Amaravadi RK,
Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno
P, Debnath J, Gewirtz DA, et al: Autophagy in malignant
transformation and cancer progression. EMBO J. 34:856–880. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dragowska WH, Weppler SA, Wang JC, Wong
LY, Kapanen AI, Rawji JS, Warburton C, Qadir MA, Donohue E, Roberge
M, et al: Induction of autophagy is an early response to gefitinib
and a potential therapeutic target in breast cancer. PLoS One.
8:e765032013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Masuelli L, Granato M, Benvenuto M,
Mattera R, Bernardini R, Mattei M, d'Amati G, D'Orazi G, Faggioni
A, Bei R and Cirone M: Chloroquine supplementation increases the
cytotoxic effect of curcumin against Her2/neu overexpressing breast
cancer cells in vitro and in vivo in nude mice while counteracts it
in immune competent mice. Oncoimmunology. 6:e13561512017.
View Article : Google Scholar : PubMed/NCBI
|
